The effects exerted by the MeD on T2DM could be attributed to the high antioxidant and anti-inflammatory properties of the whole dietary pattern, which are associated with decreased biomarkers of subclinical inflammation and increased levels of adiponectin, an anti-inflammatory cytokine inversely associated with T2DM risk [133,134]. The gene discussed is ADIPOQ; the disease is type 2 diabetes mellitus.